tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Whitney Ijem, 154 are a BUY (81.05%), 29 are a HOLD (15.26%), 7 are a SELL (3.68%).
Analyst Whitney Ijem, currently employed at CANACCORD, carries an average stock price target met ratio of 30.24% that have a potential upside of 25.29% achieved within 254 days.
Whitney Ijem’s has documented 364 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RARE, Ultragenyx at 18-Sep-2026.
Analyst best performing recommendations are on KRYS (KRYSTAL BIOTECH).
The best stock recommendation documented was for KRYS (KRYSTAL BIOTECH) at 5/30/2019. The price target of $48 was fulfilled within 48 days with a profit of $16 (50%) receiving and performance score of 10.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 23-Jun-2025
$20
$-0.11 (-0.55%)
$16
3 months 10 days ago
(09-Jul-2026)
7/17 (41.18%)
$-0.52 (-2.53%)
71
Sell Since 24-Jul-2025
$13
$-3.85 (-22.85%)
6 months 23 days ago
(26-Mar-2026)
0/2 (0%)
$-8.68 (-40.04%)
Sell Since 22-Jul-2025
6 months 23 days ago
(26-Mar-2026)
14/35 (40%)
$28.03 (127.58%)
364
Buy Since 19-Mar-2026
$37
$20.15 (119.58%)
$50
7 months ago
(19-Mar-2026)
0/16 (0%)
$20.35 (122.22%)
Buy Since 13-Mar-2026
$31
$14.15 (83.98%)
$19
7 months 6 days ago
(13-Mar-2026)
4/14 (28.57%)
$14.6 (89.02%)
322
Which stock is Whitney Ijem most bullish on?
Which stock is Whitney Ijem most reserved on?
What Year was the first public recommendation made by Whitney Ijem?
